Trials / Completed
CompletedNCT00723242
The Role of Dendritic Cells in Hepatitis C Infection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University College, London · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The role of the dendritic cells, the most potent antigen presenting cells, in the establishment of chronic hepatitis C is not established. The study aims to define whether the dendritic cells are affected by the hepatitis C virus and whether that bears an impact on the antiviral immune response they generate. The hypothesis is explored by investigating a group of patients prior to and after the initiation of standard treatment for hepatitis C with pegylated Interferon and Ribavirin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viraferon-peg and Rebetol |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2008-07-28
- Last updated
- 2008-07-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00723242. Inclusion in this directory is not an endorsement.